The phenotype of Floating-Harbor syndrome in 10 patients

Susan M White1, Angela Morgan, Annette Da Costa

  • 1Genetic Health Services Victoria, Royal Children's Hospital, Parkville, Victoria, Australia. sue.white@ghsv.org.au

Insights

Floating-Harbor syndrome (FHS) is a rare genetic disorder characterized by distinctive facial features, short stature, and speech difficulties. This study refines the FHS phenotype, noting behavioral issues and intellectual functioning variations, with no large genomic changes identified.

Area of Science:

  • Genetics
  • Pediatrics
  • Clinical Medicine

Background:

  • Floating-Harbor syndrome (FHS) presents diagnostic challenges due to subtle infantile features and overlapping symptoms with common conditions.
  • Key FHS characteristics include short stature, speech impairment, and delayed bone age, often requiring expert clinical assessment.

Purpose of the Study:

  • To refine the clinical phenotype of Floating-Harbor syndrome across a range of ages.
  • To characterize dysmorphic features, behavioral patterns, and intellectual functioning in affected individuals.
  • To investigate potential large-scale genomic causes of FHS using microarray analysis.

Main Methods:

  • Clinical evaluation of 10 individuals with FHS (ages 7-34) and a mother-daughter pair.
  • Detailed assessment of physical characteristics, including facial features and body habitus.
  • Bone age measurements, behavioral assessments, speech and language evaluations, and intellectual functioning assessments.
  • Microarray analysis in eight patients to detect copy-number variations.

Main Results:

  • Delayed bone age was observed, particularly in younger children, with some normal ranges in older individuals.
  • Characteristic facial profiles and body habitus were key diagnostic aids.
  • Most individuals exhibited significant behavioral problems, including hyperactivity and aggression.
  • Severe speech and language disorders were prevalent.
  • Intellectual functioning varied from borderline normal to moderate intellectual disability.
  • Early puberty and adult heights between 140-155 cm were noted.
  • Microarray analysis did not reveal large-scale copy-number genomic changes.

Conclusions:

  • FHS is a complex syndrome with a spectrum of clinical manifestations beyond initial descriptions.
  • Characteristic facial and body features, alongside specific developmental and behavioral patterns, are crucial for diagnosis.
  • The genetic basis of FHS does not appear to involve large-scale copy-number variations in the studied cohort.